APO Research
Talk to an analyst

APO RESEARCH · REPORT

Olanzapine Orally Disintegrating Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Olanzapine Orally Disintegrating Tablets Industry Growth and Trends Forecast to 2032

28 December 2025104 pages

Choose your research edition.

Industry ResearchOlanzapine Orally Disintegrating Tablets Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Olanzapine Orally Disintegrating Tablets Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Olanzapine Orally Disintegrating Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Olanzapine Orally Disintegrating Tablets Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Olanzapine Orally Disintegrating Tablets Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

According to APO Research, the global Olanzapine Orally Disintegrating Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Olanzapine Orally Disintegrating Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Olanzapine Orally Disintegrating Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Olanzapine Orally Disintegrating Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Olanzapine Orally Disintegrating Tablets market include Apotex, Dr. Reddy's Laboratories, PKU HealthCare, QILU Pharmaceutical, Sunshine Lake Pharma, Torrent Pharmaceuticals, Eli Lilly Nederland B.V., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Olanzapine Orally Disintegrating Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Olanzapine Orally Disintegrating Tablets market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Olanzapine Orally Disintegrating Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Olanzapine Orally Disintegrating Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Olanzapine Orally Disintegrating Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Olanzapine Orally Disintegrating Tablets Market by Company

Apotex

Dr. Reddy's Laboratories

PKU HealthCare

QILU Pharmaceutical

Sunshine Lake Pharma

Torrent Pharmaceuticals

Eli Lilly Nederland B.V.

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical

Chengdu Easton Biopharmaceuticals

Olanzapine Orally Disintegrating Tablets Segment by Type

5mg

20mg

15mg

10mg

Olanzapine Orally Disintegrating Tablets Segment by Application

Hospital

Clinic

Others

Olanzapine Orally Disintegrating Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Olanzapine Orally Disintegrating Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Olanzapine Orally Disintegrating Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Olanzapine Orally Disintegrating Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Olanzapine Orally Disintegrating Tablets companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Olanzapine Orally Disintegrating Tablets Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Olanzapine Orally Disintegrating Tablets Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Olanzapine Orally Disintegrating Tablets Market Share by Region (2021-2026) Table 4. Global Olanzapine Orally Disintegrating Tablets Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Olanzapine Orally Disintegrating Tablets Market Share by Region (2027-2032) Table 6. Global Olanzapine Orally Disintegrating Tablets Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Olanzapine Orally Disintegrating Tablets Market Size Share by Type (2021-2026) Table 9. Global Olanzapine Orally Disintegrating Tablets Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Olanzapine Orally Disintegrating Tablets Market Size Share Forecasted by Type (2027-2032) Table 11. North America Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Olanzapine Orally Disintegrating Tablets Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Olanzapine Orally Disintegrating Tablets Market Size Share by Application (2021-2026) Table 24. Global Olanzapine Orally Disintegrating Tablets Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Olanzapine Orally Disintegrating Tablets Market Size Share Forecasted by Application (2027-2032) Table 26. North America Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Olanzapine Orally Disintegrating Tablets Industry Trends Table 37. Olanzapine Orally Disintegrating Tablets Industry Drivers Table 38. Olanzapine Orally Disintegrating Tablets Industry Opportunities and Challenges Table 39. Olanzapine Orally Disintegrating Tablets Industry Restraints Table 40. Global Olanzapine Orally Disintegrating Tablets Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Company (2021-2026) Table 42. Global Olanzapine Orally Disintegrating Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Olanzapine Orally Disintegrating Tablets Key Company Headquarters & Area Served Table 44. Global Olanzapine Orally Disintegrating Tablets Company, Product Type & Application Table 45. Global Olanzapine Orally Disintegrating Tablets Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Olanzapine Orally Disintegrating Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Apotex Company Information Table 49. Apotex Business Overview Table 50. Apotex Olanzapine Orally Disintegrating Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Apotex Olanzapine Orally Disintegrating Tablets Product Portfolio Table 52. Apotex Recent Development Table 53. Dr. Reddy's Laboratories Company Information Table 54. Dr. Reddy's Laboratories Business Overview Table 55. Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets Product Portfolio Table 57. Dr. Reddy's Laboratories Recent Development Table 58. PKU HealthCare Company Information Table 59. PKU HealthCare Business Overview Table 60. PKU HealthCare Olanzapine Orally Disintegrating Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. PKU HealthCare Olanzapine Orally Disintegrating Tablets Product Portfolio Table 62. PKU HealthCare Recent Development Table 63. QILU Pharmaceutical Company Information Table 64. QILU Pharmaceutical Business Overview Table 65. QILU Pharmaceutical Olanzapine Orally Disintegrating Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. QILU Pharmaceutical Olanzapine Orally Disintegrating Tablets Product Portfolio Table 67. QILU Pharmaceutical Recent Development Table 68. Sunshine Lake Pharma Company Information Table 69. Sunshine Lake Pharma Business Overview Table 70. Sunshine Lake Pharma Olanzapine Orally Disintegrating Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Sunshine Lake Pharma Olanzapine Orally Disintegrating Tablets Product Portfolio Table 72. Sunshine Lake Pharma Recent Development Table 73. Torrent Pharmaceuticals Company Information Table 74. Torrent Pharmaceuticals Business Overview Table 75. Torrent Pharmaceuticals Olanzapine Orally Disintegrating Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Torrent Pharmaceuticals Olanzapine Orally Disintegrating Tablets Product Portfolio Table 77. Torrent Pharmaceuticals Recent Development Table 78. Eli Lilly Nederland B.V. Company Information Table 79. Eli Lilly Nederland B.V. Business Overview Table 80. Eli Lilly Nederland B.V. Olanzapine Orally Disintegrating Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Eli Lilly Nederland B.V. Olanzapine Orally Disintegrating Tablets Product Portfolio Table 82. Eli Lilly Nederland B.V. Recent Development Table 83. Sun Pharmaceutical Industries Ltd. Company Information Table 84. Sun Pharmaceutical Industries Ltd. Business Overview Table 85. Sun Pharmaceutical Industries Ltd. Olanzapine Orally Disintegrating Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Sun Pharmaceutical Industries Ltd. Olanzapine Orally Disintegrating Tablets Product Portfolio Table 87. Sun Pharmaceutical Industries Ltd. Recent Development Table 88. Teva Pharmaceutical Company Information Table 89. Teva Pharmaceutical Business Overview Table 90. Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets Product Portfolio Table 92. Teva Pharmaceutical Recent Development Table 93. Chengdu Easton Biopharmaceuticals Company Information Table 94. Chengdu Easton Biopharmaceuticals Business Overview Table 95. Chengdu Easton Biopharmaceuticals Olanzapine Orally Disintegrating Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Chengdu Easton Biopharmaceuticals Olanzapine Orally Disintegrating Tablets Product Portfolio Table 97. Chengdu Easton Biopharmaceuticals Recent Development Table 98. North America Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2026) Table 101. North America Olanzapine Orally Disintegrating Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Olanzapine Orally Disintegrating Tablets Market Share Forecast by Country (2027-2032) Table 103. Europe Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2026) Table 106. Europe Olanzapine Orally Disintegrating Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Olanzapine Orally Disintegrating Tablets Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2026) Table 111. Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Share Forecast by Country (2027-2032) Table 113. Latin America Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2026) Table 116. Latin America Olanzapine Orally Disintegrating Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America Olanzapine Orally Disintegrating Tablets Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2026) Table 121. Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Olanzapine Orally Disintegrating Tablets Product Image Figure 3. Global Olanzapine Orally Disintegrating Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 5. Global Olanzapine Orally Disintegrating Tablets Market Share by Region: 2025 VS 2032 Figure 6. Global Olanzapine Orally Disintegrating Tablets Market Share by Region (2021-2032) Figure 7. North America Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. 5mg Image Figure 13. Global 5mg Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. 20mg Image Figure 15. Global 20mg Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. 15mg Image Figure 17. Global 15mg Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. 10mg Image Figure 19. Global 10mg Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Olanzapine Orally Disintegrating Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Olanzapine Orally Disintegrating Tablets Market Share by Type 2025 VS 2032 Figure 22. North America Olanzapine Orally Disintegrating Tablets Market Size Share by Type (2021-2032) Figure 23. Europe Olanzapine Orally Disintegrating Tablets Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size Share by Type (2021-2032) Figure 25. Latin America Olanzapine Orally Disintegrating Tablets Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Olanzapine Orally Disintegrating Tablets Market Size Share by Type (2021-2032) Figure 27. Hospital Image Figure 28. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Clinic Image Figure 30. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Olanzapine Orally Disintegrating Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Olanzapine Orally Disintegrating Tablets Market Share by Application 2025 VS 2032 Figure 35. North America Olanzapine Orally Disintegrating Tablets Market Size Share by Application (2021-2032) Figure 36. Europe Olanzapine Orally Disintegrating Tablets Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size Share by Application (2021-2032) Figure 38. Latin America Olanzapine Orally Disintegrating Tablets Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Olanzapine Orally Disintegrating Tablets Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Olanzapine Orally Disintegrating Tablets Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Olanzapine Orally Disintegrating Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Olanzapine Orally Disintegrating Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2032) Figure 45. Europe Olanzapine Orally Disintegrating Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Olanzapine Orally Disintegrating Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2032) Figure 48. Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2032) Figure 51. Latin America Olanzapine Orally Disintegrating Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Olanzapine Orally Disintegrating Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2032) Figure 54. Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg
  • 20mg
  • 15mg
  • 10mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Apotex
  • Dr. Reddy's Laboratories
  • PKU HealthCare
  • QILU Pharmaceutical
  • Sunshine Lake Pharma
  • Torrent Pharmaceuticals
  • Eli Lilly Nederland B.V.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical
  • Chengdu Easton Biopharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Olanzapine Orally Disintegrating Tablets Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Olanzapine Orally Disintegrating Tablets Market Size by Region (2021-2032)
  5. 1.4.1 Global Olanzapine Orally Disintegrating Tablets Market Size by Region (2021-2026)
  6. 1.4.2 Global Olanzapine Orally Disintegrating Tablets Market Size by Region (2027-2032)
  7. 1.5 Key Regions Olanzapine Orally Disintegrating Tablets Market Size (2021-2032)
  8. 1.5.1 North America Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (2021-2032)
2 Olanzapine Orally Disintegrating Tablets Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 5mg
  3. 2.1.2 20mg
  4. 2.1.3 15mg
  5. 2.1.4 10mg
  6. 2.2 Global Olanzapine Orally Disintegrating Tablets Market Size by Type
  7. 2.2.1 Global Olanzapine Orally Disintegrating Tablets Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Olanzapine Orally Disintegrating Tablets Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Olanzapine Orally Disintegrating Tablets Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Olanzapine Orally Disintegrating Tablets Market Size by Regions
  11. 2.3.1 North America Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Type (2021-2026)
3 Olanzapine Orally Disintegrating Tablets Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Others
  5. 3.2 Global Olanzapine Orally Disintegrating Tablets Market Size by Application
  6. 3.2.1 Global Olanzapine Orally Disintegrating Tablets Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Olanzapine Orally Disintegrating Tablets Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Olanzapine Orally Disintegrating Tablets Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Olanzapine Orally Disintegrating Tablets Market Size by Regions
  10. 3.3.1 North America Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Olanzapine Orally Disintegrating Tablets Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Olanzapine Orally Disintegrating Tablets Industry Trends
  2. 4.2 Olanzapine Orally Disintegrating Tablets Industry Drivers
  3. 4.3 Olanzapine Orally Disintegrating Tablets Industry Opportunities and Challenges
  4. 4.4 Olanzapine Orally Disintegrating Tablets Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Olanzapine Orally Disintegrating Tablets Revenue (2021-2026)
  2. 5.2 Global Olanzapine Orally Disintegrating Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Olanzapine Orally Disintegrating Tablets Key Company Headquarters & Area Served
  4. 5.4 Global Olanzapine Orally Disintegrating Tablets Company, Product Type & Application
  5. 5.5 Global Olanzapine Orally Disintegrating Tablets Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Olanzapine Orally Disintegrating Tablets Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Olanzapine Orally Disintegrating Tablets Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Olanzapine Orally Disintegrating Tablets Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Apotex
  2. 6.1.1 Apotex Company Information
  3. 6.1.2 Apotex Business Overview
  4. 6.1.3 Apotex Olanzapine Orally Disintegrating Tablets Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Apotex Olanzapine Orally Disintegrating Tablets Product Portfolio
  6. 6.1.5 Apotex Recent Developments
  7. 6.2 Dr. Reddy's Laboratories
  8. 6.2.1 Dr. Reddy's Laboratories Company Information
  9. 6.2.2 Dr. Reddy's Laboratories Business Overview
  10. 6.2.3 Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets Product Portfolio
  12. 6.2.5 Dr. Reddy's Laboratories Recent Developments
  13. 6.3 PKU HealthCare
  14. 6.3.1 PKU HealthCare Company Information
  15. 6.3.2 PKU HealthCare Business Overview
  16. 6.3.3 PKU HealthCare Olanzapine Orally Disintegrating Tablets Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 PKU HealthCare Olanzapine Orally Disintegrating Tablets Product Portfolio
  18. 6.3.5 PKU HealthCare Recent Developments
  19. 6.4 QILU Pharmaceutical
  20. 6.4.1 QILU Pharmaceutical Company Information
  21. 6.4.2 QILU Pharmaceutical Business Overview
  22. 6.4.3 QILU Pharmaceutical Olanzapine Orally Disintegrating Tablets Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 QILU Pharmaceutical Olanzapine Orally Disintegrating Tablets Product Portfolio
  24. 6.4.5 QILU Pharmaceutical Recent Developments
  25. 6.5 Sunshine Lake Pharma
  26. 6.5.1 Sunshine Lake Pharma Company Information
  27. 6.5.2 Sunshine Lake Pharma Business Overview
  28. 6.5.3 Sunshine Lake Pharma Olanzapine Orally Disintegrating Tablets Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Sunshine Lake Pharma Olanzapine Orally Disintegrating Tablets Product Portfolio
  30. 6.5.5 Sunshine Lake Pharma Recent Developments
  31. 6.6 Torrent Pharmaceuticals
  32. 6.6.1 Torrent Pharmaceuticals Company Information
  33. 6.6.2 Torrent Pharmaceuticals Business Overview
  34. 6.6.3 Torrent Pharmaceuticals Olanzapine Orally Disintegrating Tablets Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Torrent Pharmaceuticals Olanzapine Orally Disintegrating Tablets Product Portfolio
  36. 6.6.5 Torrent Pharmaceuticals Recent Developments
  37. 6.7 Eli Lilly Nederland B.V.
  38. 6.7.1 Eli Lilly Nederland B.V. Company Information
  39. 6.7.2 Eli Lilly Nederland B.V. Business Overview
  40. 6.7.3 Eli Lilly Nederland B.V. Olanzapine Orally Disintegrating Tablets Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Eli Lilly Nederland B.V. Olanzapine Orally Disintegrating Tablets Product Portfolio
  42. 6.7.5 Eli Lilly Nederland B.V. Recent Developments
  43. 6.8 Sun Pharmaceutical Industries Ltd.
  44. 6.8.1 Sun Pharmaceutical Industries Ltd. Company Information
  45. 6.8.2 Sun Pharmaceutical Industries Ltd. Business Overview
  46. 6.8.3 Sun Pharmaceutical Industries Ltd. Olanzapine Orally Disintegrating Tablets Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Sun Pharmaceutical Industries Ltd. Olanzapine Orally Disintegrating Tablets Product Portfolio
  48. 6.8.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  49. 6.9 Teva Pharmaceutical
  50. 6.9.1 Teva Pharmaceutical Company Information
  51. 6.9.2 Teva Pharmaceutical Business Overview
  52. 6.9.3 Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets Product Portfolio
  54. 6.9.5 Teva Pharmaceutical Recent Developments
  55. 6.10 Chengdu Easton Biopharmaceuticals
  56. 6.10.1 Chengdu Easton Biopharmaceuticals Company Information
  57. 6.10.2 Chengdu Easton Biopharmaceuticals Business Overview
  58. 6.10.3 Chengdu Easton Biopharmaceuticals Olanzapine Orally Disintegrating Tablets Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Chengdu Easton Biopharmaceuticals Olanzapine Orally Disintegrating Tablets Product Portfolio
  60. 6.10.5 Chengdu Easton Biopharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
  3. 7.3 North America Olanzapine Orally Disintegrating Tablets Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
  3. 8.3 Europe Olanzapine Orally Disintegrating Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Olanzapine Orally Disintegrating Tablets Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
  3. 10.3 South America Olanzapine Orally Disintegrating Tablets Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst